Lantheus (LNTH) announces that its PET imaging agent MK-6240 met key study endpoints in Alzheimer's diagnosis; FDA filing ...

Company plans to file NDA in the third quarter of this yearBEDFORD, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading ...

Learn more about whether LeMaitre Vascular, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Scientists see several important uses for staging. For example, it can steer people more precisely to appropriate treatments.

Veravas, a leader in clinical diagnostics, today announced the general commercial availability of VeraBINDtm Tau, the first blood-based test designed to aid in the detection of Alzheimer's disease (AD ...

Neurology experts from UCSF Health presented new clinical research findings and cutting-edge treatment strategies and received distinguished awards recognition at the American Academy of Neurology’s ...

ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to ...

Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight ...

A stronger association between global Aβ and tau deposition was seen for individuals with an affected Alzheimer disease father vs those with an affected Alzheimer disease mother. HealthDay News ...

Imaging in live animals using clinically translatable positron emission tomography (PET) technologies for apoptosis and fibrosis showed that the addition of navitoclax doubled the amount of ...

More information: Vesa Putkinen et al, Pleasurable music activates cerebral µ-opioid receptors: a combined PET-fMRI study, European Journal of Nuclear Medicine and Molecular Imaging (2025).